Skip to main content
. Author manuscript; available in PMC: 2016 Jul 22.
Published in final edited form as: J Med Chem. 2002 Jan 3;45(1):208–218. doi: 10.1021/jm010369e

Table 2.

Synthetic Data for Nucleotide Derivatives, Including Structural Verification Using High-Resolution Mass Spectroscopy and Purity Verification Using HPLC

HPLC (rt; min)a
no. formula FAB (M − H+)
system 1
(purity) (%)
system 2
(purity) (%)
yield
(%)e
calcd found
3a C12H18N5O12P3 516.0087 516.0085 4.289 (98) 17.009d (98) 14
4a C12H16N5O6P 356.0760 356.0765 4.178 (99) 8.145d (98) 65
5a C11H17N2O14P3 492.9814 492.9832 1.737 (99) 6.764b (96) 22
6a C11H16N2O11P2 413.0151 413.0151 2.130 (98) 4.531c (97) 24
7a C11H15N2O8P 333.0488 333.0506 3.235 (99) 3.466c (98) 58
8a C12H16N5O6P 356.0760 356.0765 5.057 (97) 11.091d (99) 60
9a C12H18N5O12P3 516.0087 516.0085 5.709 (97) 17.517d (97) 30
a

Purity of each derivative was ≥ 95%, as determined using HPLC with two different mobile phases. Purity of all compounds in solvent 1 and compounds 5a, 6a, and 7a in solvent 2 was checked using an SMT OD-5-60 RP-C18 analytical column (250 × 4.6 mm; Separation Methods Technologies, Inc., Newark, DE) in two solvent systems. Compounds 3a, 4a, 8a, and 9a were checked in solvent 2 using a Phenomenex Luna 5µ C18(2) analytical column (250 × 4.6 mm). All gradients were completed in 20 min. System 1: gradient of 0.1 M TEAA/CH3CN from 95/5 to 40/60. System 2: as specified below.

b

Gradient of 5 mM TBAP/CH3CN from 80/20 to 40/60.

c

Gradient of 0.1 M TEAB/CH3CN from 100/0 to 90/10.

d

Gradient of 5 mM TBAP/CH3CN from 95/5 to 40/60.

e

The percent yields refer to overall yield for the entire phosphorylation sequence.

f

3a, MRS2340; 5a, MRS 2341.